Comorbidities should be factor in prostate biopsy choice, study finds
UC Irvine Health urologists and health policy experts report in a new study that two written assessments that identify existing comorbidities – the patient-reported Total Illness Burden Index for Prostate Cancer (TIBI-Cap) ...
Cancer
May 15, 2013 |
not rated yet |
0
New prostate cancer test improves risk assessment
(Medical Xpress)—A new genomic test for prostate cancer can help predict whether men are more likely to harbor an aggressive form of the disease, according to a new UC San Francisco study. The test, which improves risk ...
Cancer
May 08, 2013 |
not rated yet |
0
|
Gene test may help guide prostate cancer treatment
A new genetic test to gauge the aggressiveness of prostate cancer may help tens of thousands of men each year decide whether they need to treat their cancer right away or can safely monitor it.
Genetics
May 08, 2013 |
not rated yet |
0
GPS-like technology helps diagnose prostate tumors
The lead investigator of a way to obtain images of prostate tumors and accurately diagnose them said Thursday that the new technology is the medical equivalent of a global positioning system for the prostate gland.
Cancer
May 03, 2013 |
5 / 5 (1) |
0
Using genetic variants to improve PSA testing technique and reduce biopsies
With the help of genetics, prostate specific antigen (PSA) screenings may become more accurate and reduce the number of unnecessary prostate biopsies, according to a new study from Northwestern Medicine.
Cancer
Apr 24, 2013 |
5 / 5 (1) |
0
Obese men at high risk for prostate cancer even after benign biopsy
Obese men were more likely to have precancerous lesions detected in their benign prostate biopsies compared with non-obese men, and were at a greater risk for subsequently developing prostate cancer, according to researchers ...
Cancer
Apr 23, 2013 |
not rated yet |
0
Study questions value of PSA test for older men
(HealthDay)—Only one-third of men over age 65 who receive an abnormal result from their PSA test actually undergo prostate biopsy to look for disease, a new study finds.
Cancer
Apr 15, 2013 |
not rated yet |
0
|
Personalizing prostate specific antigen testing may improve specificity, reduce biopsies
Genetic variants have been identified which can increase serum prostate specific antigen (PSA) concentrations and prostate cancer risk. A new study published in The Journal of Urology reports that correcting PSA levels for th ...
Cancer
Apr 15, 2013 |
not rated yet |
0
American College of Physicians releases new prostate cancer screening guidance statement
Men between the ages of 50 and 69 should discuss the limited benefits and substantial harms of the prostate-specific antigen (PSA) test with their doctor before undergoing screening for prostate cancer, according to new recommendations ...
Cancer
Apr 08, 2013 |
not rated yet |
0
Counting copy numbers characterises prostate cancer
Non-invasive 'liquid biopsies' can find metastatic or recurrent prostate cancer, in a low cost assay suitable for most healthcare systems, finds research published in BioMed Central's open access journal Genome Medicine. Genomi ...
Cancer
Apr 04, 2013 |
not rated yet |
0
New diagnostic technology may lead to individualized treatments for prostate cancer
(Medical Xpress)—A research team jointly led by scientists from Cedars-Sinai Medical Center and the University of California, Los Angeles, have enhanced a device they developed to identify and "grab" circulating tumor cells, ...
Cancer
Apr 02, 2013 |
5 / 5 (1) |
0
|
Scientists find new gene markers for cancer risk
A huge international effort involving more than 100 institutions and genetic tests on 200,000 people has uncovered dozens of signposts in DNA that can help reveal further a person's risk for breast, ovarian ...
Genetics
Mar 27, 2013 |
5 / 5 (4) |
1
Genetic testing may be used to identify BPH patients with increased risk of prostate cancer
Patients with benign prostatic hyperplasia (BPH) carrying prostate cancer (PCa) a risk alleles are a potential target population for PCa screening and follow-up, according to a study, which was presented yesterday at the ...
Cancer
Mar 19, 2013 |
not rated yet |
0
Digital rectal exam remains important part of prostate screening
(Medical Xpress)—The digital rectal exam is an important screening test that can discover prostate cancer that a prostate-specific antigen or PSA test may not, despite the higher sensitivity of the PSA test, according to ...
Cancer
Mar 18, 2013 |
not rated yet |
0
|
PCa markers improve predictive performance of existing clinical variables
A genetic score based on PCa risk-associated single nucleotide polymorphisms (SNPs) is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology ...
Cancer
Mar 18, 2013 |
not rated yet |
0
